Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeOnc Technologies Holdings, Inc. - Common Stock (NQ:NTHI)

3.290 -0.490 (-12.96%)
Streaming Delayed Price Updated: 1:08 PM EDT, Sep 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about NeOnc Technologies Holdings, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA
From New to The Street
Via ACCESS Newswire
News headline image
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26
Dallas, Texas--(Newsfile Corp. - August 13, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). Stonegate Capital Partners Updates Coverage on... 
Via Newsfile
News headline image
NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x
Houston, Texas--(Newsfile Corp. - August 12, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) reported encouraging Phase 2a results for intranasal... 
Via Newsfile
News headline image
NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NTHI Brain Cancer Phase 2 Data Expected to Spark Triple Confluence
Houston, Texas--(Newsfile Corp. - August 11, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) is set up for a potential high... 
Via Newsfile
News headline image
NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
Call to be held Wednesday, August 12, 2026 at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time 
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors
Appointment deepens the Board’s strategic and financial oversight as the Company advances its NEO platform toward its next phase of growth 
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition
FDA feedback provides detailed manufacturing and formulation requirements for continued late-stage development of NEO212 
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy
Houston, Texas--(Newsfile Corp. - June 22, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) recently achieved what many biotechnology companies spend... 
Via Newsfile
News headline image
NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates
Houston, Texas--(Newsfile Corp. - June 15, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) continues to attract attention within the biotechnology... 
Via Newsfile
News headline image
The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade
Houston, Texas--(Newsfile Corp. - June 9, 2026) - For years, artificial intelligence has dominated conversations surrounding the future of healthcare... 
Via Newsfile
Topics Artificial Intelligence
News headline image
NeOnc Provides Business Update and Reports Q1 2026 Financial Results
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics
Via ACCESS Newswire
News headline image
NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
Dallas, Texas--(Newsfile Corp. - March 12, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI): Stonegate Capital Partners Updates Coverage on... 
Via Newsfile
News headline image
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America
Via ACCESS Newswire
News headline image
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)
Via ACCESS Newswire
News headline image
New to The Street(R) Airs Tonight on Bloomberg Television Across the U.S., MENA & Latin America
Via ACCESS Newswire
News headline image
New to The Street Broadcasts Today on Bloomberg Across the U.S., MENA, and Latin America
Via ACCESS Newswire
News headline image
NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management
Investment led by Cinctive Co-Founder Richard Schimel underscores institutional confidence in NeOnc’s biotech pipeline 
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
News headline image
Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
Dallas, Texas--(Newsfile Corp. - January 9, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). Stonegate Capital Partners initiates their coverage... 
Via Newsfile
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.